Demant AS (Denmark) Today
| DEMANT Stock | DKK 270.80 0.80 0.30% |
Performance0 of 100
| Odds Of DistressLess than 9
|
Demant AS is trading at 270.80 as of the 29th of November 2024, a 0.30 percent up since the beginning of the trading day. The stock's open price was 270.0. Demant AS has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Equity ratings for Demant AS are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 8th of June 2023 and ending today, the 29th of November 2024. Click here to learn more.
Demant AS, a hearing healthcare company, develops, manufactures, and sells products and equipment to enhance peoples hearing in Europe, North America, the Pacific, Asia, and internationally. Demant AS was founded in 1904 and is headquartered in Smrum, Denmark. The company has 223.18 M outstanding shares. More on Demant AS
Moving together with Demant Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Demant Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Demant AS's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Demant AS or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Medical Instruments & Supplies, Healthcare (View all Sectors) |
Demant AS (DEMANT) is traded on Copenhagen Exchange in Denmark and employs 20,570 people. The company currently falls under 'Large-Cap' category with a current market capitalization of 49.2 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Demant AS's market, we take the total number of its shares issued and multiply it by Demant AS's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Demant AS operates under Healthcare sector and is part of Medical Instruments & Supplies industry. The entity has 223.18 M outstanding shares.
Demant AS has accumulated about 630 M in cash with 2.62 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.57.
Check Demant AS Probability Of Bankruptcy
Ownership AllocationDemant AS holds a total of 223.18 Million outstanding shares. Demant AS shows majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 60.87 percent of Demant AS outstanding shares that are owned by insiders denotes they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Demant Ownership Details
Demant AS Risk Profiles
Although Demant AS's alpha and beta are two of the key measurements used to evaluate Demant AS's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 1.23 | |||
| Standard Deviation | 1.64 | |||
| Variance | 2.71 | |||
| Risk Adjusted Performance | (0.03) |
Demant Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Demant AS without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Global Correlations Now
Global CorrelationsFind global opportunities by holding instruments from different markets |
| All Next | Launch Module |
Demant AS Corporate Management
Elected by the shareholders, the Demant AS's board of directors comprises two types of representatives: Demant AS inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Demant. The board's role is to monitor Demant AS's management team and ensure that shareholders' interests are well served. Demant AS's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Demant AS's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Arne MBA | Pres Board | Profile | |
| Mathias Mller | Head Relations | Profile | |
| Trine KromannMikkelsen | VP Relations | Profile | |
| Finn Mohring | VP RD | Profile | |
| Niels Wagner | Member Care | Profile | |
| Sren Nielsen | Pres CEO | Profile | |
| Ren MSc | CFO Board | Profile |
Other Information on Investing in Demant Stock
Demant AS financial ratios help investors to determine whether Demant Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Demant with respect to the benefits of owning Demant AS security.